vs
EMPIRE PETROLEUM CORP(EP)与TriSalus Life Sciences, Inc.(TLSI)财务数据对比。点击上方公司名可切换其他公司
TriSalus Life Sciences, Inc.的季度营收约是EMPIRE PETROLEUM CORP的1.9倍($13.2M vs $7.1M),TriSalus Life Sciences, Inc.净利率更高(-73.9% vs -835.1%,领先761.3%),TriSalus Life Sciences, Inc.同比增速更快(59.8% vs -30.0%),过去两年TriSalus Life Sciences, Inc.的营收复合增速更高(43.0% vs -13.3%)
伊拉克石油公司,前身为土耳其石油公司,是一家石油企业,1925年至1961年间几乎垄断了伊拉克境内所有石油勘探与开采业务,由当时全球多家顶尖石油企业共同持股,公司总部设立于英国伦敦。
TriSalus生命科学公司是一家临床阶段生物技术企业,专注于免疫肿瘤学与介入肿瘤学领域,研发专有的靶向给药技术,用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果,主要在北美市场开展临床合作及业务运营。
EP vs TLSI — 直观对比
营收规模更大
TLSI
是对方的1.9倍
$7.1M
营收增速更快
TLSI
高出89.9%
-30.0%
净利率更高
TLSI
高出761.3%
-835.1%
两年增速更快
TLSI
近两年复合增速
-13.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $7.1M | $13.2M |
| 净利润 | $-59.0M | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | -834.5% | -24.8% |
| 净利率 | -835.1% | -73.9% |
| 营收同比 | -30.0% | 59.8% |
| 净利润同比 | -1306.0% | 3.5% |
| 每股收益(稀释后) | $-1.74 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EP
TLSI
| Q4 25 | $7.1M | $13.2M | ||
| Q3 25 | $9.4M | $11.6M | ||
| Q2 25 | $8.8M | $11.2M | ||
| Q1 25 | $9.0M | $9.2M | ||
| Q4 24 | $10.1M | $8.3M | ||
| Q3 24 | $11.4M | $7.3M | ||
| Q2 24 | $12.8M | $7.4M | ||
| Q1 24 | $9.4M | $6.5M |
净利润
EP
TLSI
| Q4 25 | $-59.0M | $-9.8M | ||
| Q3 25 | $-3.8M | $-10.8M | ||
| Q2 25 | $-5.1M | $-8.3M | ||
| Q1 25 | $-4.2M | $-10.4M | ||
| Q4 24 | $-4.2M | $-10.1M | ||
| Q3 24 | $-3.6M | $-2.4M | ||
| Q2 24 | $-4.4M | $-4.3M | ||
| Q1 24 | $-4.0M | $-13.2M |
毛利率
EP
TLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率
EP
TLSI
| Q4 25 | -834.5% | -24.8% | ||
| Q3 25 | -37.8% | -77.9% | ||
| Q2 25 | -56.0% | -65.4% | ||
| Q1 25 | -43.9% | -79.9% | ||
| Q4 24 | -38.9% | -91.8% | ||
| Q3 24 | -30.0% | -118.9% | ||
| Q2 24 | -15.0% | -111.0% | ||
| Q1 24 | -46.8% | -180.8% |
净利率
EP
TLSI
| Q4 25 | -835.1% | -73.9% | ||
| Q3 25 | -40.9% | -93.5% | ||
| Q2 25 | -57.8% | -73.9% | ||
| Q1 25 | -46.9% | -113.2% | ||
| Q4 24 | -41.6% | -122.4% | ||
| Q3 24 | -32.0% | -32.6% | ||
| Q2 24 | -34.3% | -58.8% | ||
| Q1 24 | -42.3% | -204.5% |
每股收益(稀释后)
EP
TLSI
| Q4 25 | $-1.74 | $-0.22 | ||
| Q3 25 | $-0.11 | $-0.96 | ||
| Q2 25 | $-0.15 | $-0.27 | ||
| Q1 25 | $-0.12 | $-0.39 | ||
| Q4 24 | $-0.12 | $-0.38 | ||
| Q3 24 | $-0.12 | $-0.12 | ||
| Q2 24 | $-0.15 | $-0.21 | ||
| Q1 24 | $-0.15 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.2M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-4.6M | $-33.9M |
| 总资产 | $65.9M | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
EP
TLSI
| Q4 25 | $1.2M | $20.4M | ||
| Q3 25 | $4.6M | $22.7M | ||
| Q2 25 | $2.3M | $26.5M | ||
| Q1 25 | $1.1M | $13.0M | ||
| Q4 24 | $2.3M | $8.5M | ||
| Q3 24 | $3.1M | $11.3M | ||
| Q2 24 | $9.3M | $16.5M | ||
| Q1 24 | $3.5M | $4.0M |
总债务
EP
TLSI
| Q4 25 | — | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $14.6M | — | ||
| Q1 25 | $11.6M | — | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.5M | — |
股东权益
EP
TLSI
| Q4 25 | $-4.6M | $-33.9M | ||
| Q3 25 | $53.7M | $-26.7M | ||
| Q2 25 | $54.5M | $-19.4M | ||
| Q1 25 | $59.1M | $-34.4M | ||
| Q4 24 | $62.8M | $-25.9M | ||
| Q3 24 | $56.5M | $-20.4M | ||
| Q2 24 | $58.7M | $-25.3M | ||
| Q1 24 | $31.7M | $-36.0M |
总资产
EP
TLSI
| Q4 25 | $65.9M | $35.3M | ||
| Q3 25 | $123.0M | $36.5M | ||
| Q2 25 | $124.7M | $41.3M | ||
| Q1 25 | $123.7M | $28.6M | ||
| Q4 24 | $123.9M | $24.0M | ||
| Q3 24 | $121.2M | $27.5M | ||
| Q2 24 | $119.9M | $32.4M | ||
| Q1 24 | $100.1M | $17.9M |
负债/权益比
EP
TLSI
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.5M |
| 自由现金流率自由现金流/营收 | — | -19.1% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-19.1M |
8季度趋势,按日历期对齐
经营现金流
EP
TLSI
| Q4 25 | $-2.8M | $-2.5M | ||
| Q3 25 | $330.0K | $-3.7M | ||
| Q2 25 | $-3.1M | $-7.3M | ||
| Q1 25 | $1.6M | $-4.5M | ||
| Q4 24 | $-8.8M | $-5.7M | ||
| Q3 24 | $12.8M | $-10.8M | ||
| Q2 24 | $-1.8M | $-13.4M | ||
| Q1 24 | $3.9M | $-10.9M |
自由现金流
EP
TLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
自由现金流率
EP
TLSI
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
资本支出强度
EP
TLSI
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图